These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17143323)

  • 21. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prion strain phenomenon: molecular basis and unprecedented features.
    Morales R; Abid K; Soto C
    Biochim Biophys Acta; 2007 Jun; 1772(6):681-91. PubMed ID: 17254754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
    Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
    Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
    Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of prion disease progression: a chemical reaction network approach.
    Méndez JM; Femat R
    IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene and cell therapy for prion diseases.
    Relaño-Ginés A; Gabelle A; Lehmann S; Milhavet O; Crozet C
    Infect Disord Drug Targets; 2009 Feb; 9(1):58-68. PubMed ID: 19200016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues.
    Hernaiz A; Sentre S; Betancor M; López-Pérez Ó; Salinas-Pena M; Zaragoza P; Badiola JJ; Toivonen JM; Bolea R; Martín-Burriel I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
    Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
    PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid cell-surface prion protein conversion revealed using a novel cell system.
    Goold R; Rabbanian S; Sutton L; Andre R; Arora P; Moonga J; Clarke AR; Schiavo G; Jat P; Collinge J; Tabrizi SJ
    Nat Commun; 2011; 2():281. PubMed ID: 21505437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection.
    Caughey B; Race RE
    Ann N Y Acad Sci; 1994 Jun; 724():290-5. PubMed ID: 8030949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion degradation pathways: Potential for therapeutic intervention.
    Goold R; McKinnon C; Tabrizi SJ
    Mol Cell Neurosci; 2015 May; 66(Pt A):12-20. PubMed ID: 25584786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.
    Hetz C; Russelakis-Carneiro M; Wälchli S; Carboni S; Vial-Knecht E; Maundrell K; Castilla J; Soto C
    J Neurosci; 2005 Mar; 25(11):2793-802. PubMed ID: 15772339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.
    Priola SA; Caughey B
    Mol Neurobiol; 1994; 8(2-3):113-20. PubMed ID: 7999307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.
    Crozet C; Lin YL; Mettling C; Mourton-Gilles C; Corbeau P; Lehmann S; Perrier V
    J Cell Sci; 2004 Nov; 117(Pt 23):5591-7. PubMed ID: 15494372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular toxicity of scrapie prions in prion diseases; a biochemical and molecular overview.
    Esmaili M; Eldeeb M
    Mol Biol Rep; 2023 Feb; 50(2):1743-1752. PubMed ID: 36446981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small RNA drugs for prion disease: a new frontier.
    Boese AS; Majer A; Saba R; Booth SA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1265-84. PubMed ID: 23848240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.